z-logo
Premium
Establishing the overlap of IONP quantification with echo and echoless MR relaxation mapping
Author(s) -
Ring Hattie L.,
Zhang Jinjin,
Klein Nathan D.,
Eberly Lynn E.,
Haynes Christy L.,
Garwood Michael
Publication year - 2018
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.26800
Subject(s) - pulse sequence , nuclear magnetic resonance , gradient echo , t2 relaxation , magnetic resonance imaging , chemistry , materials science , physics , medicine , radiology
Purpose Iron‐oxide nanoparticles (IONPs) have shown tremendous utility for enhancing image contrast and delivering targeted therapies. Quantification of IONPs has been demonstrated at low concentrations with gradient echo (GRE) and spin echo (SE), and at high concentrations with echoless sequences such as swept imaging with Fourier transform (SWIFT). This work examines the overlap of IONP quantification with GRE, SE, and SWIFT. Methods The limit of quantification of GRE, SE, inversion‐recovery GRE, and SWIFT sequences was assessed using IONPs at a concentration range of 0.02 to 89.29 mM suspended in 1% agarose. Empirically derived limits of quantification were compared with International Union of Pure and Applied Chemistry definitions. Both commercial and experimental IONPs were used. Results All three IONPs assessed demonstrated an overlap of concentration quantification with GRE, SE, and SWIFT sequences. The largest dynamic range observed was 0.004 to 35.7 mM with Feraheme. Conclusions The metrics established allow upper and lower quantitative limitations to be estimated given the relaxivity characteristics of the IONP and the concentration range of the material to be assessed. The methods outlined in this paper are applicable to any pulse sequence, IONP formulation, and field strength. Magn Reson Med 79:1420–1428, 2018. © 2017 International Society for Magnetic Resonance in Medicine.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here